E-Mail 'FDA OKs Gattex for Short Bowel Syndrome' To A Friend
Email a copy of 'FDA OKs Gattex for Short Bowel Syndrome' to a friend

Email a copy of 'FDA OKs Gattex for Short Bowel Syndrome' to a friend
(MedPage Today) — The FDA has approved teduglutide (Gattex) for use in patients with short bowel syndrome who require parenteral nutrition.
(MedPage Today) — The FDA has approved teduglutide (Gattex) for use in patients with short bowel syndrome who require parenteral nutrition.
(MedPage Today) — The FDA has approved teduglutide (Gattex) for use in patients with short bowel syndrome who require parenteral nutrition.
(MedPage Today) — The FDA has approved teduglutide (Gattex) for use in patients with short bowel syndrome who require parenteral nutrition.
(MedPage Today) — The FDA has approved teduglutide (Gattex) for use in patients with short bowel syndrome who require parenteral nutrition.
(MedPage Today) — The FDA has approved teduglutide (Gattex) for use in patients with short bowel syndrome who require parenteral nutrition.
(MedPage Today) — The FDA has approved teduglutide (Gattex) for use in patients with short bowel syndrome who require parenteral nutrition.
(MedPage Today) — The FDA has approved teduglutide (Gattex) for use in patients with short bowel syndrome who require parenteral nutrition.
(MedPage Today) — The FDA has approved teduglutide (Gattex) for use in patients with short bowel syndrome who require parenteral nutrition.
(MedPage Today) — The FDA has approved teduglutide (Gattex) for use in patients with short bowel syndrome who require parenteral nutrition.
(MedPage Today) — The FDA has approved teduglutide (Gattex) for use in patients with short bowel syndrome who require parenteral nutrition.
(MedPage Today) — The FDA has approved teduglutide (Gattex) for use in patients with short bowel syndrome who require parenteral nutrition.
(MedPage Today) — The FDA has approved teduglutide (Gattex) for use in patients with short bowel syndrome who require parenteral nutrition.